Oxford BioDynamics ( (GB:OBD) ) has shared an update.
Oxford BioDynamics has announced the granting of 218 million share options to its employees and advisers, including key directors and PDMRs, under its 2016 Employee and Non-Employee Share Option Plans. This move, with an exercise price set at the previous closing share price, aims to align the interests of the management with those of the shareholders, potentially impacting the company’s market positioning and stakeholder engagement.
More about Oxford BioDynamics
Oxford BioDynamics Plc is a precision clinical diagnostics company that specializes in developing specific and sensitive tests for medical practice using its EpiSwitch® 3D genomics platform.
YTD Price Performance: -63.20%
Average Trading Volume: 20,194,254
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £10.81M
For detailed information about OBD stock, go to TipRanks’ Stock Analysis page.